In this compelling episode of NLA Industry Innovations, host Kevin Maki, PhD, MNLA sits down with renowned lipidologist and clinical researcher Michael Davidson, MD, MNLA to explore the complex world of pharmaceutical development. Together, they unpack the science behind medical therapies—from early-stage innovation to clinical trials—and dive into the strategic decisions that shape which treatments make it to market. Dr. Davidson offers a behind-the-scenes look at how pharmaceutical compani...
All content for Industry Innovations is the property of National Lipid Association and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this compelling episode of NLA Industry Innovations, host Kevin Maki, PhD, MNLA sits down with renowned lipidologist and clinical researcher Michael Davidson, MD, MNLA to explore the complex world of pharmaceutical development. Together, they unpack the science behind medical therapies—from early-stage innovation to clinical trials—and dive into the strategic decisions that shape which treatments make it to market. Dr. Davidson offers a behind-the-scenes look at how pharmaceutical compani...
Episode 2: From Innovation to Impact: The RNA Interference Era Begins
Industry Innovations
38 minutes
6 months ago
Episode 2: From Innovation to Impact: The RNA Interference Era Begins
Dr. Bruce Given shares insights into Arrowhead Pharmaceuticals’ innovative approach to siRNA therapeutics and the company’s growing role in lipid management and cardiovascular care. Hosted by Dr. Peter Jones, this conversation highlights the intersection of clinical need and next-gen molecular science.
Industry Innovations
In this compelling episode of NLA Industry Innovations, host Kevin Maki, PhD, MNLA sits down with renowned lipidologist and clinical researcher Michael Davidson, MD, MNLA to explore the complex world of pharmaceutical development. Together, they unpack the science behind medical therapies—from early-stage innovation to clinical trials—and dive into the strategic decisions that shape which treatments make it to market. Dr. Davidson offers a behind-the-scenes look at how pharmaceutical compani...
